These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Differential cytotoxicity between transformed and normal human cells with combinations of aminonucleoside and hydroxyurea.
    Author: Bradley MO, Kohn KW, Sharkey NA, Ewig RA.
    Journal: Cancer Res; 1977 Jul; 37(7 Pt 1):2126-31. PubMed ID: 861939.
    Abstract:
    Normal human WI-38 cells can be protected from killing by hydroxyurea if proliferation is arrested during drug treatment. This protection was demonstrated both in cells arrested by density-dependent inhibition and by 3'-amino-3'deoxy-N6,N6-dimethyladenosine (puromycin aminonucleoside). In contrast, VA-13 cells (a simian virus 40-transformed clone of WI-38) were not arrested under these conditions, and continued to be sensitive to hydroxyurea. These results suggest that a search for agents that selectively and reversibly inhibit normal cycling human cells might lead to an enhancement of differential tumor toxicity.
    [Abstract] [Full Text] [Related] [New Search]